NTRA Natera Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NTRA

Price (delayed)

$261.99

Market cap

$37.52B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.62

Enterprise value

$36.66B

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 29

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a ...

Highlights
Natera's gross profit has increased by 44% YoY and by 9% QoQ
NTRA's equity is up by 43% year-on-year and by 3.6% since the previous quarter
The quick ratio has declined by 25% year-on-year and by 13% since the previous quarter
The company's debt rose by 23% YoY and by 13% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Peers: PRTA VRTX ARDX EBS

Key stats

What are the main financial stats of NTRA

NTRA stock price

How has the Natera stock price performed over time
Intraday
-1.02%
1 week
-3.46%
1 month
0.78%
1 year
85.72%
YTD
14.36%
QTD
-3.48%

Financial performance

How have Natera's revenue and profit performed over time
Revenue
$2.5B
Gross profit
$1.63B
Operating income
-$324.25M
Net income
-$226.32M
Gross margin
65.1%
Net margin
-9%
Natera's gross profit has increased by 44% YoY and by 9% QoQ
Natera's operating income has decreased by 43% YoY and by 4.6% QoQ
NTRA's revenue is up by 37% year-on-year and by 8% since the previous quarter
Natera's net income has decreased by 19% YoY and by 9% from the previous quarter

Price vs fundamentals

How does NTRA's price correlate with its fundamentals

Growth

What is Natera's growth rate over time

Valuation

What is Natera stock price valuation
P/E
N/A
P/B
20.93
P/S
14.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.66
The EPS has decreased by 10% YoY and by 7% from the previous quarter
The stock's P/B is 62% more than its 5-year quarterly average of 12.9 and 19% more than its last 4 quarters average of 17.6
NTRA's equity is up by 43% year-on-year and by 3.6% since the previous quarter
NTRA's price to sales (P/S) is 59% higher than its 5-year quarterly average of 9.3 and 26% higher than its last 4 quarters average of 11.8
NTRA's revenue is up by 37% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is Natera business performance
The return on invested capital has dropped by 88% year-on-year
The ROE has grown by 17% YoY
The ROS has decreased by 14% YoY
The ROA is up by 10% year-on-year and by 2.8% since the previous quarter

Dividends

What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRA.

Financial health

How did Natera financials performed over time
NTRA's total liabilities has surged by 71% year-on-year and by 23% since the previous quarter
NTRA's total assets has soared by 51% YoY and by 9% QoQ
The company's debt is 87% lower than its equity
NTRA's equity is up by 43% year-on-year and by 3.6% since the previous quarter
The company's debt rose by 23% YoY and by 13% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.